Physical exercise as a modulator of the purinergic system in the control of sarcopenia in individuals with chronic kidney disease on hemodialysis
Authors:
- Débora Tavares de Resende e SilvaDSDébora Tavares de Resende e Silva
- Matheus Ribeiro BizutiMBMatheus Ribeiro Bizuti
- Natan Rodrigues de OliveiraNONatan Rodrigues de Oliveira
- Lucas Zannini Medeiros LimaLLLucas Zannini Medeiros Lima
- Victória Galletti dos Santos ArraesVAVictória Galletti dos Santos Arraes
- Ana Carolina Gonçalves ZietzAZAna Carolina Gonçalves Zietz
- Carolina ZinCZCarolina Zin
- Guilherme Vinício de Sousa SilvaGSGuilherme Vinício de Sousa Silva
- Josiano Guilherme PuhleJPJosiano Guilherme Puhle
- Fabiana Brum HaagFHFabiana Brum Haag
- 27 June 2023
- journal article
- review article
- Published by Springer Nature in Purinergic Signalling
- Vol. 20 (3) , 213-222
Abstract
The word sarcopenia derives from the Greek terms “sarx” for meat and “penia” for loss, thus being used to define reductions in muscle mass, muscle strength, and lower physical performance that compromise, mainly, the elderly population. Its high negative impact on patients’ quality of life encourages the production and publication of new studies that seek to find methods to prevent and reverse cases of loss of muscle mass and strength. Furthermore, the high prevalence of sarcopenia in patients with chronic kidney disease (CKD) is closely related to its pathophysiology, which consists of a state of increased protein catabolism and decreased muscle tissue synthesis. Also considering the inflammatory nature of CKD and sarcopenia, the purinergic system has been an important target of studies, which seek to relate it to the two previous conditions. This system achieves anti-inflammatory action by inhibiting, through adenosine, pro-inflammatory factors such as interleukin-12 (IL-12), tumor necrosis factor alpha (TNF-α), and nitric oxide (NO), as well as by releasing anti-inflammatory substances such as interleukin-10 (IL-10). Simultaneously, the purinergic system presents pro-inflammatory activity, signaled by adenosine triphosphate (ATP), which occurs through the activation of T cells and the release of pro-inflammatory factors such as those mentioned above. Therefore, the ability of this system to act on inflammatory processes can promote positive and negative changes in the clinical aspect of patients with CKD and/or sarcopenia. Furthermore, it appears that there is a correlation between the practice of repeated physical exercise with the clinical improvement and in the quality of life of these patients, presenting a decrease in the levels of C-reactive protein (CRP), NTPDase, and the pro-inflammatory cytokine IL-6, such as increases in IL-10 resulting from modulation of the purinergic system. In this way, the present article seeks to evaluate the effect of physical exercise as a modulator of the purinergic system in the control of sarcopenia in patients with CKD on hemodialysis, in order to trace a relationship that can bring benefits both for biological markers and for quality of life of these patients.Keywords
Funding Information
- FAPESC
This publication has 47 references indexed in Scilit:
- Tumor necrosis factorCancer Letters, 2013
- Exercise training prevents ecto-nucleotidases alterations in platelets of hypertensive ratsMolecular and Cellular Biochemistry, 2012
- Sarcopenia in the elderly: Diagnosis, physiopathology and treatmentMaturitas, 2012
- Inflamação na doença renal crônica: papel de citocinasBrazilian Journal of Nephrology, 2011
- Morphological, Electrophysiological, and Metabolic Characteristics of Skeletal Muscle in People with End-Stage Renal Disease: A Critical ReviewPhysiotherapy Canada, 2011
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseasesNature Reviews Drug Discovery, 2008
- Exercise as a Mean to Control Low‐Grade Systemic InflammationMediators of Inflammation, 2008
- Hormonal Responses and Adaptations to Resistance Exercise and TrainingSports Medicine, 2005
- P2 receptors in the kidneyJournal of the Autonomic Nervous System, 2000
- Biological and clinical aspects of interleukin 6Immunology Today, 1990